Is Jacobson Pharma stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Jacobson Pharma pays dividends. Last time was Friday 4th of October 2024 where the investors holding the stock on Tuesday 3rd of September 2024 were paid HKD0.03 per share. Over the last 16 times between 2017 and 2024, Jacobson Pharma has paid HKD0.3186 with an average of HKD0.02 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Jacobson Pharma 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.270, you would have made a loss of HKD-0.690 per share or -54.33%
No, the average daily trading liquidity for Jacobson Pharma is HKD488 746 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Jacobson Pharma has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.86, the company's ability to pay off the debt is good. Jacobson Pharma has a good net profit margin of 16.27% and should have high tolerances against inflation.
We have calculated the inflation risk for Jacobson Pharma to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.